• Tidak ada hasil yang ditemukan

PENGARUH PEMBERIAN ASETAMINOFEN PRETREATMENT TERHADAP DERAJAT KERUSAKAN HEPAR TIKUS WISTAR YANG DIBERI DOSIS TOKSIK ASETAMINOFEN - Diponegoro University | Institutional Repository (UNDIP-IR)

N/A
N/A
Protected

Academic year: 2017

Membagikan "PENGARUH PEMBERIAN ASETAMINOFEN PRETREATMENT TERHADAP DERAJAT KERUSAKAN HEPAR TIKUS WISTAR YANG DIBERI DOSIS TOKSIK ASETAMINOFEN - Diponegoro University | Institutional Repository (UNDIP-IR)"

Copied!
5
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

1. MediMedia. MIMS Indonesia 1994; 23 (3). Singapore:MediMedia. 1994. 2. MediMedia. MIMS Indonesia 2003; 32 (2). Singapore:MediMedia. 2003.

3. Moynihan R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a year. BMJ 2002 Sept 28; 325..

4. Siker BPOM. Data keracunan parasetamol di Indonesia tahun 2002-2005, BPOM, 2006.

5. Schiodt FV, Lee WM. Fulminant liver disease. Clin Liver Dis 2003;7:331-49

6. Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis 2003;7:351-67 7. Martini. Fundamental of Anatomy and Physiology, 5th ed. London: Prentice Hall

Inc. 1999-2000.

8. Huether SE, Kathryn MC. Understanding Patophysiology, 2 nd edition. St Louis USA: Mosby Inc. 2000: 931-33.

9. Tambunan GW. Patologi gastroenterologi. Jakarta: EGC.1994: 171.

10.Doherty GM, Way LW. Liver and portal venous system. In: Doherty GM, Way LW. Current surgical diagnosis and treatment, 11th edition. Singapore: Mc Graw Hill. 2003:565-94.

11.Cotran RS,Kumar V,Collins T. Robbins: Pathologic, Basis of disease, 6 th edition. Philadelphia:WB Saunders Co. 1999:1-112.

(2)

13.Koolman J, Rohm KH.Color atlas of Biochemistry. Stuttgart: Georg Thieme Verlag. 1994. Terjemahan Indonesia oleh Dr.rer.physiol Septelia Inawati Winandi, dr. Jakarta: Hipokrates. 1995;286-88.

14.Zunilda SB, Setiawati A, Suyatna FD. Pengantar farmakologi. Dalam: Ganiswarna SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi, editors. Farmakologi dan terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian Farmakologi FK UI. 1995; 1-23.. 15.Murray RK. Metabolism of xenobiotics. In: Murray RK, Graenner DK, Mayes PA, Rodwell VW. Harper’s Biochemistry, 25 th ed. New York: Mc Graw Hill Co. 2000: 780-811.

16.Correia MA. Drug biotransformation. In: Katzung BG. Basic and Clinical pharmacology, 8 th edition. New York: Mc Graw Hill Co. 2001: 51-63. 17.Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-85.

18.Ferner RE. Forensic pharmacology:medicine, mayhem and malpractice. New York: Oxford University Press. 1996; 176-79.

19.Munstehjelm E, Munstehjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Dose-dependent inhibition acetaminophen in healthy volunteer. J Anesthesiology 2005;103: 712-17.

20.Barille FA. Clinical Toxicology: principles and mechanism.Boca Raton London New York Washington DC:CRC Press.2004;69-71.

21.Lee WM. Acute liver failure. N Engl J Med 1993 Dec 16 ; 329 : 1862-72.

22.Navarro VJ, Senior JR. Drug related hepatotoxicity. N Engl J Med 2006;354:731-39. 23.Sudiono J, Kurniadhi B, Hendrawan A, Djimantoro B. Ilmu patologi. Jakarta : EGC.

(3)

24.Stevens A, Lowe JS, Young B. Wheather’s basic histopathology: a colour atlas and text, 4th ed. Sydney: Churchill Livingstone. 2002; 6, 154-64.

25.Sacher RA, Mc Pherson RA. Wildman’s clinical interpretation of laboratory tests, 11th ed. Terjemahan Indonesia oleh Pendit U, Wulandari D. Jakarta:EGC.2004; 360-85.

26.Fischbach F. A manual of laboratory and diagnostic tests, 7th ed. Wisconsin USA: Lippincott Williams & Wilkins.2004; 386-88.

27.Wilmana FP. Analgesik-antipiretik, analgesik anti-inflamasi nonsteroid dan obat pirai. Dalam: Ganiswarna SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi, editors. Farmakologi dan terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian

Farmakologi FK UI. 1995; 214-15.

28.Furst DE, Munster T. Non steroidal anti-inflamatory drugs, disease-modifying antirheumatic drugs, non opioid analgesics, & drugs used in gout. In: Katzung BG. Basic and Clinical pharmacology, 8 th ed. New York USA: Mc Graw Hill Co. 2001: 614-16.

29.Gregus Z, Klaassen CD. Mechanisms of toxiciyt. In : Klaassen CD, editor. Casarett and doull’s toxicology the basic sciences of poisons, 6th ed. New York USA: Mc Graw Hill Co.2001:57-64.

30.Ito Y, Abril ER, Bethea NW, McCuskey RS. Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice. In: Gastrointest Liver physiology. Am J Physiol 2004; 286:G60-G67.

(4)

32.Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett 2003;144(3): 279-88.

33.Liu J, et al. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology 2003;37(2) : 324-33.

34.Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicological sciences 2006;89(1):31-41.

35.Knight B. Forensic pathology, 2 nd edition. New York : Oxford University Press. 1997; 563-64.

36.Sass DA, Shakil AO. Fulminant hepatic failure. Gastroenterol Clin N Am 2003;32:1195-211.

37.Laura P James, Wells E, Beard RH, Farrar HC. Predictor of outcome after acetaminophen poisoning in children and adolescent. Journal of pediatrics 2002 May; 140(5). St Louis USA: Mosby Inc, 2002 .

38.Hogaboam CM, et all. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. The American Journal of Pathology 2000; 156 (4): 1245-52.

39.Silvilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A risk

quantification instrument for acute acetaminophen overdose patients treated with N-acetylcystein. Ann Emerg Med 2005;46: 263-71.

(5)

41.Brooks DE, Yealy DM. Not enough relief from too much acetaminophen. Ann Emerg Med 2004;44:399-400.

42.Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337 : 1112-17.

43.Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J of Toxicol. Clinical Toxicology 2002;40(1): 3-20.

44.Kerr F, et al. The Australasian clinical toxicology Investigators collaboration Randomized trial of different loading infusion rates of N-Acetylcystein. Ann Emerg Med 2005 April; 45(4).

45.Bond GR. A new acetaminophen nomogram with a different purpose. Ann Emerg Med 2005;46: 272-74.

46.James LP, Wells E, Beard RH, Farrar HC. Predictors of outcome after

acetaminophen poisoning in children and adolescents. Journal of Pediatrics May 2002; 140(5).

47.Grunnet N, Tygstrup N, Dich J. Autoprotection against acetaminophen toxicity in cultured rat hepatocytes: the effect of pretreatment and growth factors. Pharmacol toxicol 2003;93(3): 135-41.

48.Aleksunes LM, Slitt AM, Cherrington NJ, Thibodeau MS, Klaassen CD, Manautou JE. Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride.Toxsci 2004;83 : 44-52.

Referensi

Dokumen terkait

Jumlah orang yang ikut tinggal dalam satu rumah selain keluarga inti:.. Pendapat mengenai gizi selain

[r]

Gambar 1.1 Perkembangan Rata-Rata Price Earning Ratio (PER) Pada Sub Sektor Rokok di Bursa Efek Indonesia Tahun 2004-2012

Faktor yang mempengaruhi terjadinya resiko jatuh pada lansia adalah faktor internal seperti penyakit yang diderita, gangguan penglihatan, gangguan adaptasi, gangguan

Combination of social capital in innovation and skills, natural capital in soils and landscape, and the support of media and sensitive local government, can develop local product,

Dalam konteks ini, campursari merupakan salah satu genre musik Jawa yang memadukan antara alat musik tradisional dengan alat musik moderen // Musik campursari adalah genre baru

Perbedaan Risiko Jatuh Pada Lanjut Usia Yang Mengikuti Senam Dengan Yang Tidak Mengikuti Senam Di PSTW Yogyakarta Unit Budi Luhur. Yogyakarta : FIK.STIKES AISYIYAH

Diajukan Untuk Memenuhi Sebagian dari Syarat Memperoleh Gelar Sarjana Pendidikan Pada Program Pendidikan Guru Pendidikan Anak Usia Dini.